Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Matthew Greenhawt to Peanut Hypersensitivity

This is a "connection" page, showing publications Matthew Greenhawt has written about Peanut Hypersensitivity.

 
Connection Strength
  
 
 
24.615
  
  1. Abrams EM, Shaker M, Stukus D, Mack DP, Greenhawt M. Updates in Food Allergy Prevention in Children. Pediatrics. 2023 Nov 01; 152(5).
    View in: PubMed
    Score: 0.694
  2. Bastin M, Carr WW, Davis CM, Fleischer DM, Lieberman JA, Mustafa SS, Helleputte T, Bois T, Campbell DE, Green TD, Greenhawt M. Immune response evolution in peanut epicutaneous immunotherapy for peanut-allergic children. Allergy. 2023 09; 78(9):2467-2476.
    View in: PubMed
    Score: 0.671
  3. Greenhawt M, Sindher SB, Wang J, O'Sullivan M, du Toit G, Kim EH, Albright D, Anvari S, Arends N, Arkwright PD, B?gin P, Blumchen K, Bourrier T, Brown-Whitehorn T, Cassell H, Chan ES, Ciaccio CE, Deschildre A, Divaret-Chauveau A, Dorris SL, Dorsey MJ, Eiwegger T, Erlewyn-Lajeunesse M, Fleischer DM, Ford LS, Garcia-Lloret M, Giovannini-Chami L, Hourihane JO, Jay N, Jones SM, Kerns LA, Kloepfer KM, Leonard S, Lezmi G, Lieberman JA, Lomas J, Makhija M, Parrish C, Peake J, Perrett KP, Petroni D, Pf?tzner W, Pongracic JA, Quinn P, Robison RG, Sanders G, Schneider L, Sharma HP, Trujillo J, Turner PJ, Tuttle K, Upton JE, Varshney P, Vickery BP, Vogelberg C, Wainstein B, Wood RA, Bee KJ, Campbell DE, Green TD, Rouissi R, Peillon A, Bahnson HT, Bois T, Sampson HA, Burks AW. Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy. N Engl J Med. 2023 May 11; 388(19):1755-1766.
    View in: PubMed
    Score: 0.671
  4. Greenhawt M, Abrams EM, Chalil JM, Tran O, Green TD, Shaker MS. The Impact of Allergy Specialty Care on Health Care Utilization Among Peanut Allergy Children in the United States. J Allergy Clin Immunol Pract. 2022 Dec; 10(12):3276-3283.
    View in: PubMed
    Score: 0.638
  5. Greenhawt M, Shaker M, Abrams EM. Peanut oral immunotherapy in very young children. Lancet. 2022 01 22; 399(10322):336-337.
    View in: PubMed
    Score: 0.614
  6. Greenhawt M, Oppenheimer J, Abrams EM, Peters RL, Shaker M. Leveraging shared decision making to discuss nonessential medical testing and prevent peanut allergy overdiagnosis during infancy. J Allergy Clin Immunol. 2021 07; 148(1):272-273.
    View in: PubMed
    Score: 0.583
  7. Shaker M, Chan ES, Protudjer JLP, Soller L, Abrams EM, Greenhawt M. The Cost-Effectiveness of Preschool Peanut Oral Immunotherapy in the Real-World Setting. J Allergy Clin Immunol Pract. 2021 07; 9(7):2876-2884.e4.
    View in: PubMed
    Score: 0.579
  8. Fleischer DM, Chan ES, Venter C, Spergel JM, Abrams EM, Stukus D, Groetch M, Shaker M, Greenhawt M. A Consensus Approach to the Primary Prevention of Food Allergy Through Nutrition: Guidance from the American Academy of Allergy, Asthma, and Immunology; American College of Allergy, Asthma, and Immunology; and the Canadian Society for Allergy and Clinical Immunology. J Allergy Clin Immunol Pract. 2021 01; 9(1):22-43.e4.
    View in: PubMed
    Score: 0.566
  9. DunnGalvin A, Fleischer DM, Campbell DE, O'B Hourihane J, Green TD, Sampson HA, Greenhawt M. Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE Studies. J Allergy Clin Immunol Pract. 2021 01; 9(1):216-224.e1.
    View in: PubMed
    Score: 0.556
  10. Greenhawt M, Shaker M, Wang J, Oppenheimer JJ, Sicherer S, Keet C, Swaggart K, Rank M, Portnoy JM, Bernstein J, Chu DK, Dinakar C, Golden D, Horner C, Lang DM, Lang ES, Khan DA, Lieberman J, Stukus D, Wallace D. Peanut allergy diagnosis: A?2020 practice parameter update, systematic review, and GRADE analysis. J Allergy Clin Immunol. 2020 12; 146(6):1302-1334.
    View in: PubMed
    Score: 0.556
  11. Abrams EM, Brough HA, Keet C, Shaker MS, Venter C, Greenhawt M. Pros and cons of pre-emptive screening programmes before peanut introduction in infancy. Lancet Child Adolesc Health. 2020 07; 4(7):526-535.
    View in: PubMed
    Score: 0.551
  12. Shaker M, Abrams EM, Greenhawt M. Clinician Adoption of US Peanut Introduction Guidelines-A Case for Conditional Recommendations and Contextual Considerations to Empower Shared Decision-Making. JAMA Netw Open. 2020 07 01; 3(7):e2011535.
    View in: PubMed
    Score: 0.551
  13. Greenhawt M, Kim EH, Campbell DE, Green TD, Lambert R, Fleischer DM. Improvements in eliciting dose across baseline sensitivities following 12?months of epicutaneous immunotherapy (EPIT) in peanut-allergic children aged 4 to 11 years. J Allergy Clin Immunol Pract. 2020 10; 8(9):3219-3221.
    View in: PubMed
    Score: 0.548
  14. Abrams EM, Greenhawt M. The role of peanut-free school policies in the protection of children with peanut allergy. J Public Health Policy. 2020 Jun; 41(2):206-213.
    View in: PubMed
    Score: 0.548
  15. Greenhawt M, Shaker M, Winders T, Bukstein DA, Davis RS, Oppenheimer J, Fleischer DM, Kim E, Chan ES, Stukus DR, Matlock D. Development and acceptability of a shared decision-making tool for commercial peanut allergy therapies. Ann Allergy Asthma Immunol. 2020 07; 125(1):90-96.
    View in: PubMed
    Score: 0.536
  16. Chan ES, Dinakar C, Gonzales-Reyes E, Green TD, Gupta R, Jones D, Wang J, Winders T, Greenhawt M. Unmet needs of children with peanut allergy: Aligning the risks and the evidence. Ann Allergy Asthma Immunol. 2020 05; 124(5):479-486.
    View in: PubMed
    Score: 0.535
  17. Shaker M, Chalil JM, Tran O, Vlahiotis A, Shah H, King T, Green TD, Greenhawt M. Commercial claims costs related to health care resource use associated with a diagnosis of peanut allergy. Ann Allergy Asthma Immunol. 2020 04; 124(4):357-365.e1.
    View in: PubMed
    Score: 0.534
  18. Greenhawt M, Shaker M. Determining Levers of Cost-effectiveness for Screening Infants at High Risk for Peanut Sensitization Before Early Peanut Introduction. JAMA Netw Open. 2019 12 02; 2(12):e1918041.
    View in: PubMed
    Score: 0.529
  19. Shaker M, Greenhawt M. Peanut allergy: Burden of illness. Allergy Asthma Proc. 2019 09 01; 40(5):290-294.
    View in: PubMed
    Score: 0.520
  20. Shaker MS, Iglesia E, Greenhawt M. The health and economic benefits of approaches for peanut introduction in infants with a peanut allergic sibling. Allergy. 2019 11; 74(11):2251-2254.
    View in: PubMed
    Score: 0.513
  21. Shaker M, Greenhawt M. Estimation of Health and Economic Benefits of Commercial Peanut Immunotherapy Products: A Cost-effectiveness Analysis. JAMA Netw Open. 2019 05 03; 2(5):e193242.
    View in: PubMed
    Score: 0.508
  22. Shaker MS, Greenhawt MJ. Analysis of Value-Based Costs of Undesignated School Stock Epinephrine Policies for Peanut Anaphylaxis. JAMA Pediatr. 2019 02 01; 173(2):169-175.
    View in: PubMed
    Score: 0.499
  23. Venter C, Sicherer SH, Greenhawt M. Management of Peanut Allergy. J Allergy Clin Immunol Pract. 2019 02; 7(2):345-355.e2.
    View in: PubMed
    Score: 0.499
  24. Shaker M, Greenhawt M. Association of Fatality Risk With Value-Based Drug Pricing of Epinephrine Autoinjectors for Children With Peanut Allergy: A Cost-effectiveness Analysis. JAMA Netw Open. 2018 11 02; 1(7):e184728.
    View in: PubMed
    Score: 0.491
  25. Greenhawt M, Marsh R, Gilbert H, Matlock D. Authors' response. Ann Allergy Asthma Immunol. 2018 11; 121(5):642-643.
    View in: PubMed
    Score: 0.491
  26. Shaker M, Kanaoka T, Feenan L, Greenhawt M. An economic evaluation of immediate vs non-immediate activation of emergency medical services after epinephrine use for peanut-induced anaphylaxis. Ann Allergy Asthma Immunol. 2019 01; 122(1):79-85.
    View in: PubMed
    Score: 0.481
  27. Greenhawt M, Marsh R, Gilbert H, Sicherer S, DunnGalvin A, Matlock D. Understanding caregiver goals, benefits, and acceptable risks of peanut allergy therapies. Ann Allergy Asthma Immunol. 2018 11; 121(5):575-579.
    View in: PubMed
    Score: 0.479
  28. Shaker M, Stukus D, Chan ES, Fleischer DM, Spergel JM, Greenhawt M. "To screen or not to screen": Comparing the health and economic benefits of early peanut introduction strategies in five countries. Allergy. 2018 Aug; 73(8):1707-1714.
    View in: PubMed
    Score: 0.476
  29. Shaker M, Greenhawt M. The Health and Economic Outcomes of Peanut Allergy Management Practices. J Allergy Clin Immunol Pract. 2018 Nov - Dec; 6(6):2073-2080.
    View in: PubMed
    Score: 0.475
  30. Greenhawt M, Hourihane JO. Looking into the seeds of time: Are home-based OIT programs the shape of things to come for selected patients? Ann Allergy Asthma Immunol. 2018 05; 120(5):453-454.
    View in: PubMed
    Score: 0.474
  31. Greenhawt M. Environmental exposure to peanut and the risk of an allergic reaction. Ann Allergy Asthma Immunol. 2018 05; 120(5):476-481.e3.
    View in: PubMed
    Score: 0.470
  32. Greenhawt M, Chan ES, Fleischer DM, Hicks A, Wilson R, Shaker M, Venter C, Stukus D. Caregiver and expecting caregiver support for early peanut introduction guidelines. Ann Allergy Asthma Immunol. 2018 06; 120(6):620-625.
    View in: PubMed
    Score: 0.469
  33. Greenhawt M, Oppenheimer JJ. Is the better part of valor truly discretion? Ann Allergy Asthma Immunol. 2018 02; 120(2):111-112.
    View in: PubMed
    Score: 0.466
  34. Greenhawt MJ, Fleischer DM. Primary Prevention of Food Allergy. Curr Allergy Asthma Rep. 2017 Apr; 17(4):26.
    View in: PubMed
    Score: 0.440
  35. Greenhawt M, Fleischer DM, Chan ES, Venter C, Stukus D, Gupta R, Spergel JM. LEAPing through the looking glass: secondary analysis of the effect of skin test size and age of introduction on peanut tolerance after early peanut introduction. Allergy. 2017 Aug; 72(8):1254-1260.
    View in: PubMed
    Score: 0.439
  36. Greenhawt M. The National Institutes of Allergy and Infectious Diseases sponsored guidelines on preventing peanut allergy: A new paradigm in food allergy prevention. Allergy Asthma Proc. 2017 Mar 24; 38(2):92-97.
    View in: PubMed
    Score: 0.434
  37. Couch C, Franxman T, Greenhawt M. The economic effect and outcome of delaying oral food challenges. Ann Allergy Asthma Immunol. 2016 05; 116(5):420-4.
    View in: PubMed
    Score: 0.410
  38. Greenhawt MJ, Fleischer DM, Atkins D, Chan ES. The Complexities of Early Peanut Introduction for the Practicing Allergist. J Allergy Clin Immunol Pract. 2016 Mar-Apr; 4(2):221-5.
    View in: PubMed
    Score: 0.408
  39. Greenhawt M. The Learning Early About Peanut Allergy Study: The Benefits of Early Peanut Introduction, and a New Horizon in Fighting the Food Allergy Epidemic. Pediatr Clin North Am. 2015 Dec; 62(6):1509-21.
    View in: PubMed
    Score: 0.401
  40. Greenhawt M, Chan ES, Fleischer DM. Peanut consumption in infants at risk for peanut allergy. N Engl J Med. 2015 05 28; 372(22):2164-5.
    View in: PubMed
    Score: 0.387
  41. Greenhawt MJ. STOPping peanut allergy: the saga of food oral immunotherapy. Lancet. 2014 Apr 12; 383(9925):1272-1274.
    View in: PubMed
    Score: 0.353
  42. Greenhawt MJ. Oral and sublingual peanut immunotherapy is not ready for general use. Allergy Asthma Proc. 2013 May-Jun; 34(3):197-204.
    View in: PubMed
    Score: 0.335
  43. Greenhawt M, MacGillivray F, Batty G, Said M, Weiss C. International study of risk-mitigating factors and in-flight allergic reactions to peanut and tree nut. J Allergy Clin Immunol Pract. 2013 Mar; 1(2):186-94.
    View in: PubMed
    Score: 0.331
  44. Greenhawt MJ, McMorris MS, Furlong TJ. Self-reported allergic reactions to peanut and tree nuts occurring on commercial airlines. J Allergy Clin Immunol. 2009 Sep; 124(3):598-9.
    View in: PubMed
    Score: 0.260
  45. Chua GT, Greenhawt M, Shaker M, Soller L, Abrams EM, Cameron SB, Cook VE, Erdle SC, Fleischer DM, Mak R, Vander Leek TK, Chan ES. Reply to "Peanut allergy prevention: A?mother's perspective". J Allergy Clin Immunol Pract. 2023 05; 11(5):1574-1575.
    View in: PubMed
    Score: 0.168
  46. Oriel RC, Shah A, Anagnostou A, Greenhawt M, Khan F, Leeds S, Ravindran M, Stoffels G, Vickery BP, Virkud YV, Sicherer SH. Food Allergy Management Practices Utilizing Individual Patient Thresholds: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee. J Allergy Clin Immunol Pract. 2023 04; 11(4):1083-1086.e1.
    View in: PubMed
    Score: 0.165
  47. Chua GT, Greenhawt M, Shaker M, Soller L, Abrams EM, Cameron SB, Cook VE, Erdle SC, Fleischer DM, Mak R, Vander Leek TK, Chan ES. The Case for Prompt Salvage Infant Peanut Oral Immunotherapy Following Failed Primary Prevention. J Allergy Clin Immunol Pract. 2022 10; 10(10):2561-2569.
    View in: PubMed
    Score: 0.158
  48. Lins de Holanda Coelho G, DunnGalvin A, Greenhawt M, Hourihane JO, Fleischer DM, Chen G, Shaker M, Campbell DE, Green TD, B?gin P. Psychometric parameters of food allergy quality of life during an allergen immunotherapy trial. Allergy. 2022 09; 77(9):2770-2777.
    View in: PubMed
    Score: 0.156
  49. Abrams EM, Shaker M, Greenhawt M, Mack DP. International Peanut Allergy Prevention, 6 Years After the Learning Early About Peanut Study. J Allergy Clin Immunol Pract. 2022 01; 10(1):71-77.
    View in: PubMed
    Score: 0.148
  50. Abrams EM, Greenhawt M, Alqurashi W, Singer AG, Shaker M. The Revenge of Unintended Consequences of Anaphylaxis-Risk Overdiagnosis: How Far We Have Come and How Far We Have to Go. J Allergy Clin Immunol Pract. 2021 11; 9(11):3911-3917.
    View in: PubMed
    Score: 0.147
  51. Fleischer DM, Shreffler WG, Campbell DE, Green TD, Anvari S, Assa'ad A, B?gin P, Beyer K, Bird JA, Brown-Whitehorn T, Byrne A, Chan ES, Cheema A, Chinthrajah S, Chong HJ, Davis CM, Ford LS, Gagnon R, Greenhawt M, Hourihane JO, Jones SM, Kim EH, Lange L, Lanser BJ, Leonard S, Mahler V, Maronna A, Nowak-Wegrzyn A, Oriel RC, O'Sullivan M, Petroni D, Pongracic JA, Prescott SL, Schneider LC, Smith P, Staab D, Sussman G, Wood R, Yang WH, Lambert R, Peillon A, Bois T, Sampson HA. Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results. J Allergy Clin Immunol. 2020 10; 146(4):863-874.
    View in: PubMed
    Score: 0.138
  52. Abrams EM, Soller L, Singer AG, Fleischer DM, Greenhawt M, Chan ES. Comparison of practice patterns among Canadian allergists before and after NIAID guideline recommendations. J Allergy Clin Immunol Pract. 2019 Nov - Dec; 7(8):2901-2903.e3.
    View in: PubMed
    Score: 0.127
  53. Fleischer DM, Greenhawt M, Sussman G, B?gin P, Nowak-Wegrzyn A, Petroni D, Beyer K, Brown-Whitehorn T, Hebert J, Hourihane JO, Campbell DE, Leonard S, Chinthrajah RS, Pongracic JA, Jones SM, Lange L, Chong H, Green TD, Wood R, Cheema A, Prescott SL, Smith P, Yang W, Chan ES, Byrne A, Assa'ad A, Bird JA, Kim EH, Schneider L, Davis CM, Lanser BJ, Lambert R, Shreffler W. Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial. JAMA. 2019 03 12; 321(10):946-955.
    View in: PubMed
    Score: 0.126
  54. Chan ES, Greenhawt MJ, Fleischer DM, Caubet JC. Managing Cross-Reactivity in Those with Peanut Allergy. J Allergy Clin Immunol Pract. 2019 02; 7(2):381-386.
    View in: PubMed
    Score: 0.123
  55. Lawson K, Bahnson HT, Brittain E, Sever M, Du Toit G, Lack G, Keet C, Greenhawt M, Fleischer D, Chan ES, Venter C, Stukus D, Gupta R, Spergel J. Letter of response to Greenhawt et?al. 'LEAPing Through the Looking Glass: Secondary Analysis of the Effect of Skin Test Size and Age of Introduction on Peanut Tolerance after Early Peanut Introduction'. Allergy. 2017 08; 72(8):1267-1271.
    View in: PubMed
    Score: 0.113
  56. Togias A, Cooper SF, Acebal ML, Assa'ad A, Baker JR, Beck LA, Block J, Byrd-Bredbenner C, Chan ES, Eichenfield LF, Fleischer DM, Fuchs GJ, Furuta GT, Greenhawt MJ, Gupta RS, Habich M, Jones SM, Keaton K, Muraro A, Plaut M, Rosenwasser LJ, Rotrosen D, Sampson HA, Schneider LC, Sicherer SH, Sidbury R, Spergel J, Stukus DR, Venter C, Boyce JA. Addendum Guidelines for the Prevention of Peanut Allergy in the United States: Summary of the National Institute of Allergy and Infectious Diseases-Sponsored Expert Panel. J Acad Nutr Diet. 2017 05; 117(5):788-793.
    View in: PubMed
    Score: 0.111
  57. Togias A, Cooper SF, Acebal ML, Assa'ad A, Baker JR, Beck LA, Block J, Byrd-Bredbenner C, Chan ES, Eichenfield LF, Fleischer DM, Fuchs GJ, Furuta GT, Greenhawt MJ, Gupta RS, Habich M, Jones SM, Keaton K, Muraro A, Plaut M, Rosenwasser LJ, Rotrosen D, Sampson HA, Schneider LC, Sicherer SH, Sidbury R, Spergel J, Stukus DR, Venter C, Boyce JA. Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel. Ann Allergy Asthma Immunol. 2017 02; 118(2):166-173.e7.
    View in: PubMed
    Score: 0.108
  58. Togias A, Cooper SF, Acebal ML, Assa'ad A, Baker JR, Beck LA, Block J, Byrd-Bredbenner C, Chan ES, Eichenfield LF, Fleischer DM, Fuchs GJ, Furuta GT, Greenhawt MJ, Gupta RS, Habich M, Jones SM, Keaton K, Muraro A, Plaut M, Rosenwasser LJ, Rotrosen D, Sampson HA, Schneider LC, Sicherer SH, Sidbury R, Spergel J, Stukus DR, Venter C, Boyce JA. Addendum guidelines for the prevention of peanut allergy in the United States: Summary of the National Institute of Allergy and Infectious Diseases-sponsored expert panel. Pediatr Dermatol. 2017 Jan; 34(1):5-12.
    View in: PubMed
    Score: 0.108
  59. Togias A, Cooper SF, Acebal ML, Assa'ad A, Baker JR, Beck LA, Block J, Byrd-Bredbenner C, Chan ES, Eichenfield LF, Fleischer DM, Fuchs GJ, Furuta GT, Greenhawt MJ, Gupta RS, Habich M, Jones SM, Keaton K, Muraro A, Plaut M, Rosenwasser LJ, Rotrosen D, Sampson HA, Schneider LC, Sicherer SH, Sidbury R, Spergel J, Stukus DR, Venter C, Boyce JA. Addendum Guidelines for the Prevention of Peanut Allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-Sponsored Expert Panel. Pediatr Dermatol. 2017 Jan; 34(1):e1-e21.
    View in: PubMed
    Score: 0.108
  60. Togias A, Cooper SF, Acebal ML, Assa'ad A, Baker JR, Beck LA, Block J, Byrd-Bredbenner C, Chan ES, Eichenfield LF, Fleischer DM, Fuchs GJ, Furuta GT, Greenhawt MJ, Gupta RS, Habich M, Jones SM, Keaton K, Muraro A, Plaut M, Rosenwasser LJ, Rotrosen D, Sampson HA, Schneider LC, Sicherer SH, Sidbury R, Spergel J, Stukus DR, Venter C, Boyce JA. Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel. J Allergy Clin Immunol. 2017 Jan; 139(1):29-44.
    View in: PubMed
    Score: 0.108
  61. Togias A, Cooper SF, Acebal ML, Assa'ad A, Baker JR, Beck LA, Block J, Byrd-Bredbenner C, Chan ES, Eichenfield LF, Fleischer DM, Fuchs GJ, Furuta GT, Greenhawt MJ, Gupta RS, Habich M, Jones SM, Keaton K, Muraro A, Plaut M, Rosenwasser LJ, Rotrosen D, Sampson HA, Schneider LC, Sicherer SH, Sidbury R, Spergel J, Stukus DR, Venter C, Boyce JA. Addendum Guidelines for the Prevention of Peanut Allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-Sponsored Expert Panel. J Pediatr Nurs. 2017 Jan - Feb; 32:91-98.
    View in: PubMed
    Score: 0.108
  62. Fleischer DM, Sicherer S, Greenhawt M, Campbell D, Chan E, Muraro A, Halken S, Katz Y, Ebisawa M, Eichenfield L, Sampson H, Lack G, Du Toit G, Roberts G, Bahnson H, Feeney M, Hourihane J, Spergel J, Young M, As'aad A, Allen K, Prescott S, Kapur S, Saito H, Agache I, Akdis CA, Arshad H, Beyer K, Dubois A, Eigenmann P, Fernandez-Rivas M, Grimshaw K, Hoffman-Sommergruber K, Host A, Lau S, O'Mahony L, Mills C, Papadopoulos N, Venter C, Agmon-Levin N, Kessel A, Antaya R, Drolet B, Rosenwasser L. Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants. Allergy. 2015 Oct; 70(10):1193-5.
    View in: PubMed
    Score: 0.099
  63. Fleischer DM, Sicherer S, Greenhawt M, Campbell D, Chan E, Muraro A, Halken S, Katz Y, Ebisawa M, Eichenfield L, Sampson H, Lack G, Du Toit G, Roberts G, Bahnson H, Feeney M, Hourihane J, Spergel J, Young M, As'aad A, Allen K, Prescott S, Kapur S, Saito H, Agache I, Akdis CA, Arshad H, Beyer K, Dubois A, Eigenmann P, Fernandez-Rivas M, Grimshaw K, Hoffman-Sommergruber K, Host A, Lau S, O'Mahony L, Mills C, Papadopoulos N, Venter C, Agmon-Levin N, Kessel A, Antaya R, Drolet B, Rosenwasser L. Consensus Communication on Early Peanut Introduction and Prevention of Peanut Allergy in High-Risk Infants. Pediatr Dermatol. 2016 Jan-Feb; 33(1):103-6.
    View in: PubMed
    Score: 0.099
  64. Fleischer DM, Sicherer S, Greenhawt M, Campbell D, Chan E, Muraro A, Halken S, Katz Y, Ebisawa M, Eichenfield L, Sampson H, Lack G, Du Toit G, Roberts G, Bahnson H, Feeney M, Hourihane J, Spergel J, Young M, As'aad A, Allen K, Prescott S, Kapur S, Saito H, Agache I, Akdis CA, Arshad H, Beyer K, Dubois A, Eigenmann P, Fernandez-Rivas M, Grimshaw K, Hoffman-Sommergruber K, Host A, Lau S, O'Mahony L, Mills C, Papadopoulos N, Venter C, Agmon-Levin N, Kessel A, Antaya R, Drolet B, Rosenwasser L. Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants. Ann Allergy Asthma Immunol. 2015 Aug; 115(2):87-90.
    View in: PubMed
    Score: 0.097
  65. Fleischer DM, Sicherer S, Greenhawt M, Campbell D, Chan E, Muraro A, Halken S, Katz Y, Ebisawa M, Eichenfield L, Sampson H, Lack G, Du Toit G, Roberts G, Bahnson H, Feeney M, Hourihane J, Spergel J, Young M, As'aad A, Allen K, Prescott S, Kapur S, Saito H, Agache I, Akdis CA, Arshad H, Beyer K, Dubois A, Eigenmann P, Fernandez-Rivas M, Grimshaw K, Hoffman-Sommergruber K, Host A, Lau S, O'Mahony L, Mills C, Papadopoulos N, Venter C, Agmon-Levin N, Kessel A, Antaya R, Drolet B, Rosenwasser L. Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants. J Allergy Clin Immunol. 2015 Aug; 136(2):258-61.
    View in: PubMed
    Score: 0.097
  66. Yuan I, Greenhawt M, Shaker M. An update on international practice variation in peanut introduction: conundrums, controversies, and a new direction. Curr Opin Pediatr. 2020 12; 32(6):825-831.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)